ABUS vs ROST · P/E 5.4, rev $6.2M vs P/E 21, rev $21.13B
Arbutus Biopharma Corp (ABUS) versus Ross Stores Inc (ROST) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Ross Stores Inc (ROST) is a apparel retail company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported ROST revenue for 2025-02-01 was $21.13B. Net income was $2.09B. Revenue was up 3.7% from 2024-02-03 to 2025-02-01. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
Not investment advice. Open the ABUS and ROST stock pages for the full models.
Not investment advice.